Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 30;15(8):1663.
doi: 10.3390/v15081663.

The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation

Affiliations
Review

The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation

Peter G E Kennedy. Viruses. .

Abstract

Varicella-Zoster virus (VZV) is a pathogenic human alpha herpes virus that causes varicella (chicken pox) as a primary infection and, following a variable period of latency in different ganglionic neurons, it reactivates to produce herpes zoster (shingles). The focus of this review is on the wide spectrum of the possible neurological manifestations of VZV reactivation. While the most frequent reactivation syndrome is herpes zoster, this may be followed by the serious and painful post-herpetic neuralgia (PHN) and by many other neurological conditions. Prominent among these conditions is a VZV vasculopathy, but the role of VZV in causing giant cell arteritis (GCA) is currently controversial. VZV reactivation can also cause segmental motor weakness, myelitis, cranial nerve syndromes, Guillain-Barre syndrome, meningoencephalitis, and zoster sine herpete, where a neurological syndrome occurs in the absence of the zoster rash. The field is complicated by the relatively few cases of neurological complications described and by the issue of causation when a neurological condition is not manifest at the same time as the zoster rash.

Keywords: Varicella–Zoster virus (VZV); herpes zoster; latency; neurology; neuron; post-herpetic neuralgia (PHN); reactivation; vasculitis; virus.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

Cited by

References

    1. Kennedy P.G.E., Gershon A.A. Clinical features of Varicella-Zoster virus infection of the nervous system. Viruses. 2018;10:609. doi: 10.3390/v10110609. - DOI - PMC - PubMed
    1. Kennedy P.G.E., Grinfeld E., Gow J.W. Latent varicella–zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl. Acad. Sci. USA. 1998;95:4658–4662. doi: 10.1073/pnas.95.8.4658. - DOI - PMC - PubMed
    1. Gershon A.A., Breuer J., Cohen J.I., Cohrs R.J., Gershon M.D., Gilden D., Grose C., Hambleton S., Kennedy P.G.E., Oxman M., et al. Varicella zoster virus infection. Nat. Rev. Dis. Prim. 2015;1:15016. doi: 10.1038/nrdp.2015.16. - DOI - PMC - PubMed
    1. Kennedy P.G.E., Rovnak J., Badani H., Cohrs R.J. A comparison of herpes simplex virus type 1 andvaricella-zoster virus latency and reactivation. Pt 7J. Gen. Virol. 2015;96:1581–1602. doi: 10.1099/vir.0.000128. - DOI - PMC - PubMed
    1. Cohrs R.J., Barbour M., Gilden D.H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: Detection of transcripts to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 1996;70:2789–2796. doi: 10.1128/jvi.70.5.2789-2796.1996. - DOI - PMC - PubMed